Sildenafil potential in oncology treatment via cholesterol pathway inhibition

Research suggests sildenafil may inhibit tumor cell growth by restricting cholesterol supply, with potential synergistic effects when combined with statins. The findings remain in early-stage investigation, and clinical efficacy in human cancer patients is not yet established.